Riskpilot← Back to searchSign inGet full accessBergmans Konst & Terapi AB
ABActiveOrg 5569309130Nygatan 8Retail sale of cultural and recreational goods n.e.c. · NACE 4769Est. 20131-4 employees
Revenue 2024
SEK 6,1M
+4% vs 2023
EBITDA margin
0.1%
+100% vs 2023
Equity ratio
14.3%
Financial strength
Net profit 2024
SEK -123K
+73% vs 2023
| Revenue | SEK 6,1M | +4% |
| EBITDA | SEK 4K | +100% |
| Net profit | SEK -123K | +73% |
| Total assets | SEK 3,1M | -5% |
| Equity | SEK 439K | -22% |
| Employees | — | — |
Legal name
Bergmans Konst & Terapi AB
Org number
5569309130
Legal form
Aktiebolag
NACE code
4769 · Retail sale of cultural and recreational goods n.e.c.
Founded
3 maj 2013
Share capital
SEK 150 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva utställningsverksamhet inom konst och även ha samtalsterapi inom kognitiv samtalsterapi samt idka därmed förenlig verksamhet, dels och utveckla och förvalta såväl fast som lös egendom.
Address
Nygatan 8
Email
mats@galleribergman.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 940 | 8 393 | 7 189 | 5 923 | 6 132 |
| Staff expenses | — | — | — | — | −1 244 |
| EBITDA | 1 127 | 700 | 129 | −1 078 | 4 |
| Depreciation & amort. | −0 | −4 | −4 | −4 | −4 |
| EBIT | 1 127 | 696 | 125 | −1 082 | 0 |
| Net financials | −17 | −33 | −26 | −160 | −123 |
| Profit before tax | 834 | 525 | 159 | −457 | −123 |
| Tax | −184 | −112 | −46 | 1 | — |
| Net profit | 650 | 413 | 113 | −456 | −123 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 052 | 3 531 | 3 998 | 3 218 | 3 069 |
| Equity | 1 031 | 1 144 | 1 017 | 562 | 439 |
| Long-term debt | 68 | 0 | 463 | 502 | 531 |
| Short-term debt | 1 246 | 1 542 | 1 732 | 2 155 | 2 099 |
| Total debt | 1 314 | 1 542 | 2 195 | 2 657 | 2 631 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20202024
Equity ratio
14.3%
This company
38.2%
Market median
-63% vs market
20202024
Return on equity
-28.0%
This company
18.4%
Market median
-252% vs market
20202024
Net profit margin
-2.0%
This company
8.1%
Market median
-125% vs market
20202024
Asset turnover
2.00×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
6.00×
This company
0.62×
Market median
-868% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EL Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AN Auditor Substitute | Auditor Substitute | 2022 – 2024 |
OD Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bergmans Konst & Terapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexandra Nancy Maria Ryen | Auditor Substitute | 0 companies |
| Emil Lars-Henrik Pettersson | Chief Auditor | 0 companies |
| Oskar David Georg Forsberg | Chief Auditor | 0 companies |
| Mats Thure Bergman | Board of Directors | 0 companies |
| Berit Ingmarie Helgesson Bergman | Deputy Board Member | 0 companies |